Literature DB >> 19242743

Dietary n-3 and n-6 PUFA enhance DHA incorporation in retinal phospholipids without affecting PGE(1) and PGE (2) levels.

Coralie Schnebelen1, Stéphane Grégoire, Bruno Pasquis, Corinne Joffre, Catherine P Creuzot-Garcher, Alain M Bron, Lionel Bretillon, Niyazi Acar.   

Abstract

The purpose of this study was to determine whether dietary n-3 and n-6 PUFA may affect retinal PUFA composition and PGE(1) and PGE(2) production. Male Wistar rats were fed for 3 months with diets containing: (1) 10% eicosapentaenoic acid (EPA) and 7% docosahexaenoic acid (DHA), or (2) 10% gamma-linolenic acid (GLA), or (3) 10% EPA, 7% DHA and 10% GLA, or (4) a balanced diet deprived of EPA, DHA, and GLA. The fatty acid composition of retinal phospholipids was determined by gas chromatography. Prostaglandin production was measured by enzyme immunoassay. When compared to rats fed the control diet, the retinal levels of DHA were increased in rats fed both diets enriched with n-3 PUFA (EPA + DHA and EPA + DHA + GLA diets) and decreased in those supplemented with n-6 PUFA only (GLA diet). The diet enriched with both n-6 and n-3 PUFA resulted in the greatest increase in retinal DHA. The levels of PGE(1) and PGE(2) were significantly increased in retinal homogenates of rats fed with the GLA-rich diet when compared with those of animals fed the control diet. These higher PGE(1) and PGE(2) levels were not observed in animals fed with EPA + DHA + GLA. In summary, GLA added to EPA + DHA resulted in the highest retinal DHA content but without increasing retinal PGE(2) as seen in animals supplemented with GLA only.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242743     DOI: 10.1007/s11745-009-3289-3

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  27 in total

Review 1.  Dietary modification of inflammation with lipids.

Authors:  Philip C Calder
Journal:  Proc Nutr Soc       Date:  2002-08       Impact factor: 6.297

2.  Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans.

Authors:  J B Barham; M B Edens; A N Fonteh; M M Johnson; L Easter; F H Chilton
Journal:  J Nutr       Date:  2000-08       Impact factor: 4.798

3.  Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men.

Authors:  D S Kelley; P C Taylor; G J Nelson; B E Mackey
Journal:  Lipids       Date:  1998-02       Impact factor: 1.880

Review 4.  Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development.

Authors:  B Koletzko; C Agostoni; S E Carlson; T Clandinin; G Hornstra; M Neuringer; R Uauy; Y Yamashiro; P Willatts
Journal:  Acta Paediatr       Date:  2001-04       Impact factor: 2.299

5.  Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.

Authors:  D Santoli; R B Zurier
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

7.  Diets rich in eicosapentaenoic acid and gamma-linolenic acid affect phospholipid fatty acid composition and production of prostaglandins E1, E2 and E3 in turbot (Scophthalmus maximus), a species deficient in delta 5 fatty acid desaturase.

Authors:  J G Bell; D R Tocher; F M MacDonald; J R Sargent
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1995-10       Impact factor: 4.006

8.  Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.

Authors:  Peiying Yang; Diana Chan; Edward Felix; Carrie Cartwright; David G Menter; Timothy Madden; Russell D Klein; Susan M Fischer; Robert A Newman
Journal:  J Lipid Res       Date:  2004-03-01       Impact factor: 5.922

9.  Differential tissue dose responses of (n-3) and (n-6) PUFA in neonatal piglets fed docosahexaenoate and arachidonoate.

Authors:  Meng-Chuan Huang; J Thomas Brenna; Angela Chueh Chao; Carolyn Tschanz; Deborah A Diersen-Schade; Hsin-Chia Hung
Journal:  J Nutr       Date:  2007-09       Impact factor: 4.798

10.  First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula.

Authors:  S E Carlson; R J Cooke; S H Werkman; E A Tolley
Journal:  Lipids       Date:  1992-11       Impact factor: 1.880

View more
  5 in total

1.  Polyunsaturated fatty acids induce modification in the lipid composition and the prostaglandin production of the conjunctival epithelium cells.

Authors:  Sabrina Viau; Laurent Leclère; Bénédicte Buteau; Stéphane Grégoire; Niyazi Acar; Alain Bron; Catherine P Creuzot-Garcher; Lionel Bretillon; Corinne Joffre
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-06       Impact factor: 3.117

2.  Plasma Fatty Acids Pattern and Dry Eye Disease in the Elderly: The Montrachet Population-Based Study.

Authors:  Alassane Seydou; Louis Arnould; Pierre-Henry Gabrielle; Florian Baudin; Ines Ben Ghezala; Alain M Bron; Niyazi Acar; Catherine Creuzot-Garcher
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

3.  New approach to modulate retinal cellular toxic effects of high glucose using marine epa and dha.

Authors:  Mélody Dutot; Violaine de la Tourrette; Roxane Fagon; Patrice Rat
Journal:  Nutr Metab (Lond)       Date:  2011-06-16       Impact factor: 4.169

4.  Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice.

Authors:  Virginie F Labrousse; Agnès Nadjar; Corinne Joffre; Laurence Costes; Agnès Aubert; Stéphane Grégoire; Lionel Bretillon; Sophie Layé
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Dietary supplement enriched in antioxidants and omega-3 protects from progressive light-induced retinal degeneration.

Authors:  Khaoula Ramchani-Ben Othman; Christine Cercy; Mohamed Amri; Michel Doly; Isabelle Ranchon-Cole
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.